Discover the full record of transactions filed by Lazar David E.. Insider active across 10 companies, notably FiEE, Inc.. Cumulatively, 20 disclosures have been logged. Split: 3 buys · 4 sells. Total volume traded: €8.6m. Activity tracked since 6 July 2022. The latest transaction was disclosed on 4 August 2026 (C). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lazar David E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1,165,975 股@ US$0.773510.4% 占其流量Common Stock, par value $0.001SEC:0001829126-22-014209:0
标准退出：2022年10月4日 (T+90)
20 条申报中的 20 条
About Lazar David E.
Lazar David E. has 15 filings in total. In the 15 sampled filings, the transactions span from 2022-07-08 to 2026-04-02, with EUR 966741 of purchases and EUR 7656891 of sales, and no primary role is stated. He is listed as Chief Executive Officer at Titan Pharmaceuticals INC, as President at LQR House Inc., as Director at MINIM, INC. and Sow Good Inc., and with no stated role at Cyclacel Pharmaceuticals, Inc. and NovaBay Pharmaceuticals, Inc.